Rational design, synthesis, and structure-activity relationship of benzoxazolones: New potent mglu5 receptor antagonists based on the fenobam structure

被引:26
|
作者
Ceccarelli, Siniona M. [1 ]
Jaeschke, Georg
Buettelmann, Bernd
Huwyler, Joerg
Kolczewski, Sabine
Peters, Jens-Uwe
Prinssen, Eric
Porter, Richard
Spooren, Will
Vieira, Eric
机构
[1] F Hoffmann La Roche & Co Ltd, Div Pharmaceut, Discovery Res, CH-4070 Basel, Switzerland
[2] Univ Appl Sci, Northwestern Switzerland Inst Pharma Technol, CH-4132 Muttenz, Switzerland
关键词
mGluR5; fenobam; anxiety; MPEP; benzoxazolone;
D O I
10.1016/j.bmcl.2006.12.006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel class of potent and stable mGlu5 receptor antagonists was developed by combining information from a high-throughput screening campaign with the structure of the known anxiolytic fenobam. Representative compounds from this class show favorable pharmacokinetic properties and are active in an in vivo model of anxiety. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1302 / 1306
页数:5
相关论文
共 50 条
  • [21] Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity
    Spanka, Carsten
    Glatthar, Ralf
    Desrayaud, Sandrine
    Fendt, Markus
    Orain, David
    Troxler, Thomas
    Vranesic, Ivo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 184 - 188
  • [22] Novel potent neuropeptide YY5 receptor antagonists: Synthesis and structure-activity relationships of phenylpiperazine derivatives
    Takahashi, Toshiyuki
    Sakuraba, Aya
    Hirohashi, Tomoko
    Shibata, Takunobu
    Hirose, Masaaki
    Haga, Yuji
    Nonoshita, Katsumasa
    Kanno, Tetsuya
    Ito, Junko
    Iwaasa, Hisashi
    Kanatani, Akio
    Fukami, Takehiro
    Sato, Nagaaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (22) : 7501 - 7511
  • [23] Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists
    Laine, Dramane I.
    Yan, Hongxing
    Xie, Haibo
    Davis, Roderick S.
    Dufour, Jeremy
    Widdowson, Katherine L.
    Palovich, Michael R.
    Wan, Zehong
    Foley, James J.
    Schmidt, Dulcie B.
    Hunsberger, Gerald E.
    Burman, Miriam
    Bacon, Alicia M.
    Webb, Edward F.
    Luttmann, Mark A.
    Salmon, Michael
    Sarau, Henry M.
    Umbrecht, Sandra T.
    Landis, Philip S.
    Peck, Brian J.
    Busch-Petersen, Jakob
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (09) : 3366 - 3369
  • [24] Synthesis and structure-activity relationship of a new series of potent angiotensin II receptor antagonists:: Pyrazolo[1,5-α]pyrimidine derivatives
    Shiota, T
    Yamamori, T
    Sakai, K
    Kiyokawa, M
    Honma, T
    Ogawa, M
    Hayashi, K
    Ishizuka, N
    Matsumura, K
    Hara, M
    Fujimoto, M
    Kawabata, T
    Nakajima, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (07) : 928 - 938
  • [25] Design, synthesis, and structure-activity relationship of novel CCR2 antagonists
    Kothandaraman, Shankaran
    Donnely, Karla L.
    Butora, Gabor
    Jiao, Richard
    Pasternak, Alexander
    Morriello, Gregori J.
    Goble, Stephen D.
    Zhou, Changyou
    Mills, Sander G.
    MacCoss, Malcolm
    Vicario, Pasquale P.
    Ayala, Julia M.
    DeMartino, Julie A.
    Struthers, Mary
    Cascieri, Margaret A.
    Yang, Lihu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1830 - 1834
  • [26] Synthesis and structure-activity relationship of a new series of potent AT(1) selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles
    Almansa, C
    Gomez, LA
    Cavalcanti, FL
    deArriba, AF
    GarciaRafanell, J
    Forn, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (04) : 547 - 558
  • [27] Novel spiropyrazolone antitumor scaffold with potent activity: Design, synthesis and structure-activity relationship
    Wu, Shanchao
    Li, Yu
    Xu, Guixia
    Chen, Shuqiang
    Zhang, Yongqiang
    Liu, Na
    Dong, Guoqiang
    Miao, Chaoyu
    Su, Hua
    Zhang, Wannian
    Sheng, Chunquan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 115 : 141 - 147
  • [28] Structure and Function Studies of the mGlu5 Receptor in the Design of Novel Negative Allosteric Modulators
    Bennett, Kirstie A.
    Dore, Andrew S.
    Okrasa, Krzysztof
    Patel, Jayesh C.
    Serrano-Vega, Maria
    Cooke, Robert M.
    Errey, James C.
    Jazayeri, Ali
    Tehan, Ben
    Wiggin, Giselle R.
    Christopher, John A.
    Marshall, Fiona H.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 3 - 4
  • [29] Structure-Activity Relationship of Adenosine 5′-diphosphoribose at the Transient Receptor Potential Melastatin 2 (TRPM2) Channel: Rational Design of Antagonists
    Moreau, Christelle
    Kirchberger, Tanja
    Swarbrick, Joanna M.
    Bartlett, Stephen J.
    Fliegert, Ralf
    Yorgan, Timur
    Bauche, Andreas
    Harneit, Angelika
    Guse, Andreas H.
    Potter, Barry V. L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (24) : 10079 - 10102
  • [30] Design, Synthesis, and Structure-Activity Relationship of Novel Potent and Highly Selective Cysteinyl Leukotriene Receptor 1 (CysLT1R) Antagonists
    Wang Jingyi
    Liu Jinyu
    Chen Dongsheng
    Chen Huayan
    Xie Xin
    Nan Fajun
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2024, 44 (01) : 259 - 276